Cost-effectiveness of introducing a maternal vaccine or long-acting monoclonal antibody to prevent infant respiratory syncytial virus disease in Nepal. - Rave N; Sharma AK; Chapagain RH; Nguyen A; Pecenka C; Shaaban FL; Bont LJ; Clark A (Journal of global health, 2025)